IV Levosimendan Mixed Blessing for Outpatients

HFC 2013 — LISBON — Repeated doses of IV levosimendan given to outpatients with end-stage heart failure failed to improve functional capacity or quality of life, despite some positive outcomes, a placebo-controlled trial showed.


< Back to Listings